Navigation Links
HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
Date:2/25/2008

les generally accepted in the United States

and should not be considered as an alternative to net income (loss) or

to cash flows from operating, investing, or financing activities.

Because Adjusted Consolidated EBITDA is not a measure determined in

accordance with generally accepted accounting principles and is

susceptible to varying calculations, Adjusted Consolidated EBITDA, as

presented, may not be comparable to other similarly titled measures

presented by other companies.

Our Credit Agreement allows certain items to be added to arrive at

Adjusted Consolidated EBITDA that are viewed as not being ongoing

costs once the Company has completed its restructuring.

After consummation of the divestitures of our surgery centers,

outpatient, and diagnostic divisions, and in accordance with our

Credit Agreement, Adjusted Consolidated EBITDA is calculated to give

effect to each divestiture, including adjustments for the allocation

of corporate overhead to each divested division. However, these

allocations are estimates and are not necessarily indicative of the

Adjusted Consolidated EBITDA that would have resulted had the

applicable divisions been divested as of the beginning of each period

presented. Accordingly, these adjustments are not included in the

above table. In addition, we are allowed to add other income,

including interest income, to the calculation of Adjusted Consolidated

EBITDA under our Credit Agreement. This includes interest income

associated with our federal income tax recovery. This amount has not

been included in the above calculation as it would not be indicative

of our Adjusted Consolidated EBITDA for future periods.

Adjusted Consolidated EBITDA for the year ended December 31, 2007

inc
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Issues Statement on Medicare Bill and 75% Rule
3. HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government
4. HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
5. HealthSouth Announces Date of Third Quarter Earnings Conference Call
6. HealthSouth Corporation Appoints New Member to Board of Directors
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. NHP Reports Fourth Quarter and Full Year 2007 Earnings
9. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
10. Clarity for Consumers on Botox Complication and Death Reports
11. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... by HIV/AIDS in South Africa may provide insight on ... issues in other areas of the world, which may ... could lead to successful interventions. , A report ... Nations mentions that due to the HIV/AIDS pandemic, which ... children are at an increased risk for mental health ...
(Date:4/14/2014)... and American Associations for Dental Research (IADR/AADR) have ... Their Dental, Oral, and Craniofacial Manifestations." The complete ... Burke, Alison M. Boyce, Michael Collins, Brian L. ... Scott Ramnitz, Martha J. Somerman and J. Timothy ... the IADR/AADR Journal of Dental Research ...
(Date:4/14/2014)... IL A new study shows that moderate to ... increased risk of stroke, cancer and death. , Results ... moderate to severe obstructive sleep apnea were four times ... four times more likely to have a stroke (HR ... cancer (HR = 3.4), and 2.5 times more likely ...
(Date:4/14/2014)... 10, 2014. John DeLuca, PhD, and Yael Goverover, PhD, ... study how persons with multiple sclerosis (MS) perform everyday ... Reality to Measure Everyday Life Functional Activity in Multiple ... DeLuca is senior VP of Research & Training at ... York University, is a visiting scientist at Kessler Foundation. ...
(Date:4/14/2014)... a UT Dallas study involving serious youth offenders, the answer ... the next seven years: "How long do you think you,ll ... future encourages offending over time., Author Dr. Alex Piquero said ... life ahead of them offend at very high rates and ... to die much later in life offend much less., "In ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Rare bone diseases and their dental, oral and craniofacial manifestations 2Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2
... ... in Europe to Treat Neovascular AMD Patients with New Epimacular Brachytherapy System , ... Fremont, CA and Pisa, ... patients have been treated following the commercialization of the VIDON® ANV® Therapy System, the ...
... 12 Zimmer Holdings, Inc. (NYSE: ... the Securities and Exchange Commission an automatic shelf registration statement on ... of equity and debt securities and that it intends, subject to ... a benchmark size. , The Company intends to use the ...
... PARI Respiratory Equipment launched a newly ... Efficient Aerosol Delivery, rounding out their free learning ... case managers, and pharmacists. The updated class ... for caregivers to update their skills and receive ...
... 12 Bausch & Lomb, the global eye health company, ... Board of Directors. , Mr. Hassan was chairman and ... Merck & Co., Inc. on November 3. Before joining Schering-Plough, ... chairman and CEO (from 2001 to 2003) of Pharmacia Corporation ...
... cancer cells in lab study , THURSDAY, Nov. 12 (HealthDay ... leukemia holds promise as a possible treatment for ovarian cancer, ... used to treat chronic myeloid leukemia. Researchers at the University ... the growth and invasive powers of ovarian cancer cells. ...
... , ... Nikolai Tankovich, MD, Ph.D., President and Chief Medical Officer of Stemedica Cell Technologies, ... Science and Society at Trinity College, a constituent college of the University of ... for stem cells, was attended by more than 300 professors and staff representing ...
Cached Medicine News:Health News:NeoVista, Inc. Announces First Neovascular AMD Patient Treated with VIDION ANV Therapy System in Europe Following Commercialization 2Health News:NeoVista, Inc. Announces First Neovascular AMD Patient Treated with VIDION ANV Therapy System in Europe Following Commercialization 3Health News:Zimmer Holdings, Inc. Announces Offering of Senior Notes 2Health News:PARI Respiratory Equipment Offers New Respiratory Management Course 2Health News:Fred Hassan Joins Bausch & Lomb Board of Directors 2Health News:Leukemia Drug May Help Some Ovarian Cancer Patients 2Health News:Stemedica President Invited To Lecture At The University Of Oxford 2Health News:Stemedica President Invited To Lecture At The University Of Oxford 3
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... company developing its Symphony® CGM System as a ... that Robert F. Doman , Executive Chairman ... at "TEN", Noble Financial Capital Markets, Tenth Annual ... make a corporate presentation to prospective corporate partners ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals ... VRX) announced that the applicable waiting period under the ... to the previously announced tender offer by its indirect ... the outstanding shares of common stock of Solta Medical, ... price of $2.92 per share, net to the seller ...
(Date:1/14/2014)... 14, 2014 HeartWare International, Inc ... innovator of less invasive, miniaturized circulatory support technologies ... failure, today announced that it expects revenues for ... $53 million, bringing expected full-year 2013 revenues to ... growth of 87% for 2013 above 2012 reflects ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Perrigo Company (Nasdaq: PRGO ; TASE) today announced ... fiscal 2010 on Monday, November 2, 2009 at approximately 8:00 ... at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo,s ... be available live via webcast to interested parties on the ...
... As previously announced, WebMD Health Corp. (Nasdaq: WBMD ) ... Annual Meetings of Stockholders beginning at 9:30 a.m. Eastern Time on ... of the meetings will be available over the Internet. To listen ... www.wbmd.com (in the Investor Relations section) or at ...
Cached Medicine Technology:WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: